生命科学资讯

Top drug regulator Rick Pazdur plans to leave FDA

Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug

As approval date looms, Cytokinetics gears up for David-and-Goliath battle with Bristol Myers

Helicore stops work on clinical GIP antagonist after Phase 1 results

Trial Library raises $10M to sell clinical trial matching to insurers

Imvax shares Phase 2b data for glioblastoma treatment, plans to meet with FDA

Vandria plots Series B raise to advance Alzheimer’s drug into Phase 2

House passes bill to reauthorize rare pediatric PRV program; Senate next

New ACIP chair claims Covid-19 vaccines caused cancer, miscarriages

Janux’s prostate cancer immunotherapy’s response rate drops, according to new early-stage data

FDA and Prasad's Covid vaccine death claims lack key details

Belite Bio aims for first approval of Stargardt disease treatment with Phase 3 success

UK to spend more on medicines for US tariff exemption

Angelini, European Investment Bank join forces; Radiopharma startup raises $40M

Lilly slightly lowers self-pay prices for single-dose vials of Zepbound

Biopharma Sentiment Index | Q4 2025

"Heavy AI" is taking over biopharma | Signal Pulse Report

Introducing Endpoints Signal — intelligence for fresh biopharma insights

Gene writing startup Tessera strikes $150M partnership with Regeneron

Protego gets $130M for AL amyloidosis drug from leaders behind Vyndaqel